Clearpoint Neuro Inc (CLPT)
ClearPoint Neuro, Inc. is a Nasdaq-listed common stock company in the healthcare equipment and supplies sector. The company develops and commercializes medical device platforms used for minimally invasive brain procedures performed under magnetic resonance imaging guidance. Its ClearPoint system is designed to support the placement of deep brain stimulation electrodes, biopsy needles, and laser catheters, and to facilitate the infusion of pharmaceuticals into the brain.
The company has entered into license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V., UCB Biopharma SRL, NE Scientific, LLC, the University of California, San Francisco, and Johns Hopkins University. Formerly known as MRI Interventions, Inc., the company adopted the ClearPoint Neuro name in February 2020. Incorporated in 1998, ClearPoint Neuro is headquartered in Solana Beach, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CLPT
|
$9.60
|
-37.4% Downside
|
Overvalued
|
$28.33
|
84.7% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 11, 2026
|
-15.9x
|
24.5x
|
11.4x
|
451.3 M
|
490.4 M
|
12.3%
|
87.6%
|
-0.6
|
—
|
91.9%
|
